Cardiff University
Also known as: Cardiff and Vale NHS | Cardiff and Vale University Health Board | Cardiff Univeristy | Cardiff University | Centre for Trials Research, Cardiff University | Common Cold Centre, Cardiff School of Biosciences, Cardiff University | Department of Wound Healing, Cardiff University | Institute of Infection and Immunity, Cardiff University School of Medicine | Llandudno Hospital & University of College Wales | School of Medicine and School of Biosciences, Cardiff University, Cardiff, UK | School of Psychology, Cardiff University | University Hospital, Cardiff, United Kingdom | University Hospital of Wales | University Hospital of Wales and Rookwood Hospital | University Hospital of Wales, Cardiff, UK | University of Cardiff | Wales Cancer Trials Unit
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1994Last known activity
Jan 31, 2021
Timeline
1880s
- Jan 1, 1883
Cardiff University— Founded
Drugs by trial phase (100 distinct, 60 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (46 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adrenal Insufficiency
- Agammaglobulinemia
- Anemia, Refractory, with Excess of Blasts
- Anus Neoplasms
- Arachnodactyly
- Arthritis
- Arthritis, Rheumatoid
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Transitional Cell
- Carcinosarcoma
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Common Cold
- Common Variable Immunodeficiency
- Communicable Diseases
- Critical Illness
- Dementia
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Embolism
- Endometrial Neoplasms
- Esophageal and Gastric Varices
- Esophageal Neoplasms
- Eye Diseases
- Fatigue
- Graves Disease
- Graves Ophthalmopathy
- Hemophilia A
- Hypercalcemia
- Hypopituitarism
- Immunologic Deficiency Syndromes
- Infections
- Invasive Fungal Infections
- Kidney Neoplasms
- Leg Ulcer
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Lung Injury
- Lung Neoplasms
- Lymphangioleiomyomatosis
- Marfan Syndrome
- Mesothelioma
- Mixed Tumor, Mullerian
- Multiple Myeloma
- Mycoses
- Myelitis
- Myelitis, Transverse
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neuromyelitis Optica
- Neutropenia
- Oropharyngeal Neoplasms
- Pancreatic Neoplasms
- Parkinson Disease
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Pulmonary Embolism
- Purpura, Thrombocytopenic, Idiopathic
- Rectal Neoplasms
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Schizophrenia
- Sclerosis
- Skin Ulcer
- Staphylococcal Infections
- Syndrome
- Thrombocytopenia
- Thromboembolism
- Thrombosis
- Tuberous Sclerosis
- Ulcer
- Ureteral Neoplasms
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Varicose Ulcer
- Varicose Veins
- Venous Thromboembolism
- Venous Thrombosis
Recent trials (50)
- NCT04688983Lead sponsorPhase 2Jan 31, 2021
- NCT04545151Overall official - principal investigatorPhase 2Nov 30, 2020
- NCT04046133Lead sponsorPhase 1Nov 1, 2019
- NCT05872698CollaboratorPhase 4Jun 1, 2019
- NCT03776955CollaboratorPhase 4Apr 30, 2019
- NCT03653832CollaboratorPhase 3Sep 30, 2018
- NCT03570437CollaboratorPhase 2May 17, 2018
- NCT03156452CollaboratorPhase 3Sep 1, 2017
- NCT03750110CollaboratorN/AJul 1, 2017
- NCT03241108Overall official - principal investigatorPhase 2May 10, 2017
- NCT02837094Study directorPhase 1Sep 29, 2016
- NCT02837094Lead sponsorPhase 1Sep 29, 2016
- NCT05604118Lead sponsorN/AAug 1, 2016
- NCT02741856Lead sponsorPhase 2/Phase 3Jun 1, 2016
- NCT02139904Lead sponsorPhase 2Mar 1, 2016
Details
- Founded
- Cardiff, GB Jan 1, 1883
- Last known activity
- Jan 31, 2021